Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten 
sensitive skin disease - Dermatitis herpetiformis

Lytton, Simon D.; Antiga, Emiliano; Pfeiffer, Sascha; Matthias, Torsten; Szaflarska-Poplawska, Anna; Ulaganathan, Vijay Kumar; Placek, Waldemar; Fabbri, Paolo; Hall, Russell; Caproni, Marzia

doi:10.1016/j.cca.2012.10.051

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease - Dermatitis herpetiformis

MPS-Authors

/persons/resource/persons39102

Ulaganathan, Vijay Kumar
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Lytton, S. D., Antiga, E., Pfeiffer, S., Matthias, T., Szaflarska-Poplawska, A., Ulaganathan, V. K., et al. (2013). Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease - Dermatitis herpetiformis. CLINICA CHIMICA ACTA, 415, 346-349. doi:10.1016/j.cca.2012.10.051.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-E5E8-B

Abstract

Background: The deamidated gliadin peptides (DGP) cross linked to human tissue transglutaminase (tTg) comprises a novel neo-epitope structure (Neo-tTg) for serological screening of celiac disease (CD). Our aim is to verify anti-Neo-tTg IgA and IgG in adults with dermatitis herpetiformis (DH). Methods: Multi-centric retrospective evaluation of the IgA/G autoantibodies in sera of DH patients on a regular diet (n=40) and a gluten restricted diet (GRD, n=53) and control adults with autoimmune skin diseases (n=107) by ELISA. Results: The sensitivities of Celicheck Neo IgA/G (76%, 95% CI 67-84%) and the Neo tTg-A (85%, 95% CI 70-97%) ELISA were significantly greater than that of tTg-A (56%, 95% CI 46-67%), eTg-A (62%, 95% CI 52-72%), DGP-A (55%, 95% CI 55-65%), DGP-G (61%, 95% CI 51-71%), Glia-A (55%, 95% CI 45-65%) and Glia-G (56%, 95% CI 46-66%) ELISA. The specificities of all 8 ELISA were in the range of 90-100%. The area under the curve (AUC) of receiver operator characteristic curve (ROC) for the two Neo-tTg ELISA (0.863 and 0.949) were higher than the AUCs for ROCs of tTg, DGP and eTG ELISA (range between 0.657 and 0.783). The autoantibody levels of DH patients on a normal diet were significantly higher than those on GRD in the Celicheck Neo IgA/IgG, NeotTg-A; tTg-A and the eTg-A; ELISA (p<0.01) and of no significance in the DGP and Gliadin ELISA. Conclusion: Neo-epitope IgA autoantibodies represent a new and sensitive sbrological marker of DH. (C) 2012 Elsevier B.V. All rights reserved.